Clinical significance of MMP-2 and MMP-9 in patients with oral cancer

被引:109
作者
Patel, Beena P.
Shah, Shakuntala V.
Shukla, Shilin N.
Shah, Pankaj M.
Patel, Prabhudas S. [1 ]
机构
[1] Gujarat Canc Res Inst, Div Biochem Res, Ahmadabad 380016, Gujarat, India
[2] Gujarat Canc Res Inst, Dept Surg Oncol, Ahmadabad 380016, Gujarat, India
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2007年 / 29卷 / 06期
关键词
matrix metalloproteinases; squamous cell carcinomas; oral cancer; invasion; metastasis;
D O I
10.1002/hed.20561
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Factors that represent the potential for invasion and metastasis, such as matrix metalloproteinases (MMPs), could predict prognosis of cancer. Therefore, the authors studied plasma and tissue levels of MMP-2 and MMP-9 in oral cancer, the leading malignancy in India. Methods. Enzyme-linked immunosorbent assay and gelatin zymography were used for the MMP analysis from plasma and tissue samples, respectively. Results. Latent, active, and total forms and activation ratio of MMP-2 and MMP-9 were significantly elevated in malignant tissues as compared with adjacent normal tissues. Activation of MMP-2 was higher than MMP-9 in malignant tissues. Activation ratio was significantly higher in malignant tissues of the patients with lymph node metastasis as compared with those without lymph node metastasis (p = .005). Plasma MMP-9 levels were significantly lower in responders as compared with pretreatment levels (p = .002). Conclusion. The data indicate that MMP-2 and MMP-9 can be useful to identify metastatic phenotype as well as for treatment monitoring in oral cancer. (c) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:564 / 572
页数:9
相关论文
共 29 条
[1]  
*AM JOINT COMM CAN, 1997, CANC STAG MAN
[2]  
Arenas-Huertero FJ, 1999, J EXP CLIN CANC RES, V18, P279
[3]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[4]  
Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO
[5]  
2-C
[6]  
Endo K, 1997, ANTICANCER RES, V17, P2253
[7]  
GARBISA S, 1992, CANCER RES, V52, P4548
[8]  
GOJHI K, 1998, INT J CANCER, V79, P96
[9]  
Gupta PC, 1999, ORAL DIS, V5, P1
[10]   BASEMENT-MEMBRANE TYPE IV COLLAGEN IN ORAL SQUAMOUS-CELL CARCINOMA [J].
HIROTA, J ;
YONEDA, K ;
OSAKI, T .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1990, 12 (05) :400-405